Organigram Global (OGI) Free Cash Flow (2018 - 2026)
Organigram Global (OGI) posted quarterly Free Cash Flow of -$14.9 million for Q1 2026, down 112.3% year-on-year from $121.2 million in Q1 2025, and down 49.48% on a QoQ basis from -$10.0 million in Q4 2025.
Organigram Global (OGI) Free Cash Flow (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Free Cash Flow for 7 consecutive years, with -$14.9 million the latest figure, recorded in Q1 2026.
- Quarterly Free Cash Flow fell 112.3% year-over-year to -$14.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31.9 million (down 260.48% YoY) and the FY2025 annual result came in at -$17.9 million, down 2740.22% from the prior year.
- Free Cash Flow eased to -$14.9 million in Q1 2026 per OGI's latest filing, from -$10.0 million in the prior quarter.
- Over the last five years, Free Cash Flow for OGI reached as high as -$1.8 million in Q4 2024 and fell as low as -$14.9 million in Q1 2026.
- A 3-year average of -$8.4 million and a median of -$8.5 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2025 — Free Cash Flow plunged 445.54% — and 2026, when it plunged 112.3%.
- Year by year, Free Cash Flow stood at -$1.8 million in 2024, then tumbled by 445.54% to -$10.0 million in 2025, then slumped by 49.48% to -$14.9 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$14.9 million, -$10.0 million, and -$7.0 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | -14.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.91 Mn |
| Mar 31, 2026 | -14.91 Mn |
| Dec 31, 2025 | -9.97 Mn |
| Dec 31, 2025 | -9.97 Mn |
| Mar 31, 2025 | -7.02 Mn |
| Mar 31, 2025 | -7.02 Mn |
| Dec 31, 2024 | -1.83 Mn |
| Dec 31, 2024 | -1.83 Mn |
| May 31, 2021 | -14.51 Mn |
| May 31, 2021 | -14.51 Mn |
| Feb 28, 2021 | -42.78 Bn |
| Feb 28, 2021 | -42.78 Bn |
| Nov 30, 2020 | 79.30 Bn |
| Nov 30, 2020 | 79.30 Bn |
| Aug 31, 2020 | -12.10 Mn |
| Aug 31, 2020 | -12.10 Mn |
| May 31, 2020 | 23.73 Mn |
| May 31, 2020 | 23.73 Mn |
| Feb 29, 2020 | -39,962.00 |
| Feb 29, 2020 | -39,962.00 |